Accumulate Sun Pharma: Sajiv Dhawan, JV Capital Services

Sajiv Dhawan, MD, JV Capital Services, in a chat with ET Now talks about Sun Pharma and other pharma stocks.

What is the call on Ranbaxy in particular and pharma pack in general?

Ranbaxy is a stock which a lot of investors do like. But it has not really been the best of stocks recently. If you want to take a pick, then look at Sun Pharma. It has performed better from the stock market perspective and even on the declines, it represents decent value.

Pharma on any given day can have some bad news coming from overseas on drug approvals. If there is some good news, obviously the stocks rally. Some bad news and the stocks do collapse. The stocks have been pretty relatively firm in an overall pretty poor market. But for us, Sun Pharma would be the one that we will advise investors to accumulate.